CN115698157A - Reactive phosphate and preparation process thereof - Google Patents

Reactive phosphate and preparation process thereof Download PDF

Info

Publication number
CN115698157A
CN115698157A CN202080101474.9A CN202080101474A CN115698157A CN 115698157 A CN115698157 A CN 115698157A CN 202080101474 A CN202080101474 A CN 202080101474A CN 115698157 A CN115698157 A CN 115698157A
Authority
CN
China
Prior art keywords
group
formula
compound
hydrogen
independently selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080101474.9A
Other languages
Chinese (zh)
Inventor
叶思宇
E·王
E·鲍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Blue Cube Intellectual Property Co ltd
Original Assignee
Blue Cube Intellectual Property Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blue Cube Intellectual Property Co ltd filed Critical Blue Cube Intellectual Property Co ltd
Publication of CN115698157A publication Critical patent/CN115698157A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657172Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and one oxygen atom being part of a (thio)phosphinic acid ester: (X = O, S)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/12Esters of phosphoric acids with hydroxyaryl compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2404Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2408Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of hydroxyalkyl compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F290/00Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
    • C08F290/02Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated end groups
    • C08F290/06Polymers provided for in subclass C08G
    • C08F290/062Polyethers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G79/00Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule
    • C08G79/02Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule a linkage containing phosphorus
    • C08G79/04Phosphorus linked to oxygen or to oxygen and carbon
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D155/00Coating compositions based on homopolymers or copolymers, obtained by polymerisation reactions only involving carbon-to-carbon unsaturated bonds, not provided for in groups C09D123/00 - C09D153/00
    • C09D155/005Homopolymers or copolymers obtained by polymerisation of macromolecular compounds terminated by a carbon-to-carbon double bond

Abstract

Provided herein are phosphorus-based flame retardant compounds that provide good electrical properties and good heat resistance properties when incorporated into PCB compositions. In particular, provided herein are novel organophosphorus based polymers containing C = C double bonds that allow them to react with other components (e.g., C = C bond terminated polyphenylene ethers, unsaturated hydrocarbon resins, bismaleimides, etc.) to form a crosslinked network.

Description

Reactive phosphate and preparation process thereof
Background
Continued advances in computer engineering have created an increased demand for high speed, low loss printed circuit board ("PCB") materials. High-speed, low-loss PCB materials exhibit a smaller variation in dielectric constant (Dk) with increasing transmission frequency and exhibit relatively low dielectric loss, as compared to previous generations of PCB materials.
Recently, it has become particularly important to develop a high-speed, low-loss PCB material which is halogen-free and exhibits an excellent low dissipation factor (Df). Formulations known in the art are typically based on thoroughly cured resin systems, for example, systems comprising hydrocarbon resins rich in C = C double bonds, acrylate-capped polyphenylene ethers (PPEs) and/or crosslinkers rich in C = C double bonds.
Unfortunately, there is a lack of phosphorus-based flame retardants with a Df low enough to be useful in these high performance PCB systems. Currently known reactive flame retardants do not provide the desired electrical performance characteristics. While certain additive-type flame retardants, such as resorcinol bis [ bis (2, 6-dimethylphenyl) phosphate ], will provide desirable electrical performance characteristics, these additive-type flame retardants will significantly reduce the heat resistance of the compositions, including the glass transition temperature (Tg) and the decomposition temperature (Td).
Accordingly, it is desirable to develop alternatives to existing phosphorus-based flame retardants that provide good electrical properties and good heat resistance properties. In particular, there is a need in the art for alternative phosphorus-based flame retardants that provide comparable (or better than) electrical performance characteristics to resorcinol bis [ bis (2, 6-dimethylphenyl) phosphate ], while also providing improved heat resistance characteristics relative to resorcinol bis [ bis (2, 6-dimethylphenyl) phosphate ].
Disclosure of Invention
There is provided herein a compound of formula a,
Figure BDA0003966987840000011
wherein each Ar is 1 Independently is part of structure (1);
Figure BDA0003966987840000021
R 1 、R 2 and R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may optionally beIndependently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy and carboxyl;
R 4 and R 5 Each independently is a moiety comprising at least one C = C double bond;
each Ar 2 Independently selected from the group consisting of structure (4), structure (5), structure (6), structure (7), structure (8), and structure (9);
Figure BDA0003966987840000022
Figure BDA0003966987840000031
each X is independently selected from the group consisting of-CH 2 -、-C(CH 3 ) 2 -、-S-、-SO 2 -, -O-and-CO-; r 6 And R 7 Each independently selected from the group consisting of hydrogen and alkyl, aryl, alkoxy, and aryloxy groups, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl; and n is an integer greater than or equal to 1.
Also provided herein are compounds of formula I,
Figure BDA0003966987840000032
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
each Ar 2 Independently selected from the group consisting of structure (4), structure (5), structure (6), structure (7), structure (8), and structure (9);
each X is independently selected from the group consisting of-CH 2 -、-C(CH 3 ) 2 -、-S-、-SO 2 -, -O-and-CO-;
R 6 and R 7 Each independently selected from the group consisting of hydrogen and alkyl, aryl, alkoxy, and aryloxy groups, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
and n is an integer greater than or equal to 1.
Also provided herein are compounds of formula II,
Figure BDA0003966987840000041
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
each Ar 2 Independently selected from the group consisting of structure (4), structure (5), structure (6), structure (7), structure (8), and structure (9);
each X is independently selected from the group consisting of-CH 2 -、-C(CH 3 ) 2 -、-S-、-SO 2 -, -O-and-CO-;
R 6 and R 7 Each independently selected from the group consisting of hydrogen and alkyl, aryl, alkoxy, and aryloxy groups, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
and n is an integer greater than or equal to 1.
Further provided herein are compounds of formula III,
Figure BDA0003966987840000042
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxyEach of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy and carboxyl;
each Ar 2 Independently selected from the group consisting of structure (4), structure (5), structure (6), structure (7), structure (8), and structure (9);
each X is independently selected from the group consisting of-CH 2 -、-C(CH 3 ) 2 -、-S-、-SO 2 -, -O-and-CO-;
R 6 and R 7 Each independently selected from the group consisting of hydrogen and alkyl, aryl, alkoxy, and aryloxy groups, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
and n is an integer greater than or equal to 1.
Also provided herein are curable unsaturated resin compositions, wherein the composition comprises at least one unsaturated resin and a flame retardant compound selected from the group consisting of formula a, formula I, formula Ia, formula II, formula IIa, formula IIb, formula IIc, formula IId, formula IIe, formula IIf, formula III, formula IIIa, formula IIIb, formula IIIc, formula IIId, formula IIIe, and formula IIIf.
As used herein, the term "unsaturated resin" refers to a resin that includes at least one C = C double bond.
Also provided herein are cured unsaturated resin compositions, wherein the unsaturated resin composition comprises a flame retardant compound selected from the group consisting of formula a, formula I, formula Ia, formula II, formula IIa, formula IIb, formula IIc, formula IId, formula IIe, formula IIf, formula III, formula IIIa, formula IIIb, formula IIIc, formula IIId, formula IIIe, and formula IIIf.
Also provided herein are printed circuit boards comprising a cured unsaturated resin composition, wherein the unsaturated resin composition comprises a flame retardant compound selected from the group consisting of formula a, formula I, formula Ia, formula II, formula IIa, formula IIb, formula IIc, formula IId, formula IIe, formula IIf, formula III, formula IIIa, formula IIIb, formula IIIc, formula IIId, formula IIIe, and formula IIIf.
Other objects and features will be in part apparent and in part pointed out hereinafter.
Detailed Description
Provided herein are phosphorus-based flame retardant compounds that provide good electrical properties and good heat resistance properties.
In particular, provided herein are novel organophosphorus-based polymers containing C = C double bonds that allow them to react with other components (e.g., C = C double-capped polyphenylene ethers, unsaturated hydrocarbon resins, bismaleimides, etc.) to form a crosslinked network. Surprisingly, it has been found that these reactive compounds provide good dielectric properties and heat resistance when incorporated into PCB compositions.
For example, provided herein are compounds of formula A,
Figure BDA0003966987840000061
wherein each Ar is 1 Independently is part of structure (1);
Figure BDA0003966987840000062
R 1 、R 2 and R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
R 4 and R 5 Each independently is a moiety comprising at least one C = C double bond;
each Ar 2 Independently selected from the group consisting of structure (4), structure (5), structure (6), structure (7), structure (8), and structure (9);
Figure BDA0003966987840000063
Figure BDA0003966987840000071
each X is independently selected from the group consisting of-CH 2 -、-C(CH 3 ) 2 -、-S-、-SO 2 -, -O-and-CO-;
R 6 and R 7 Each independently selected from the group consisting of hydrogen and alkyl, aryl, alkoxy, and aryloxy groups, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
and n is an integer greater than or equal to 1.
In a preferred embodiment, R 4 And R 5 Each independently selected from the group consisting of structure (1), structure (2), and structure (3);
Figure BDA0003966987840000072
as used herein, the term "alkyl" refers to a straight or branched chain moiety comprising up to (up to) 10 carbon atoms. Non-limiting examples of suitable alkyl groups include methyl, ethyl, propyl, butyl, pentyl, and hexyl. The alkyl group may be a straight chain alkyl group or a branched alkyl group (e.g., isopropyl group). In some embodiments, the alkyl is optionally independently substituted with one or more substituents selected from the group consisting of methoxy, carboxy.
As used herein, the term "aryl" refers to an aromatic moiety comprising 6 to 14 carbon atoms. In some embodiments, aryl is optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxy. Non-limiting examples of suitable aryl groups include phenyl, naphthyl, benzyl, tolyl, and methylbenzyl.
As used herein, the term "alkoxy" refers to a group that forms-OR ', wherein R' is an alkyl group as defined herein. For example, the group-OCH 3 May be referred to herein as "methoxy". radical-OCH 2 CH 3 May be referred to herein as "ethoxy".
As used herein, the term "aryloxy" refers to a group that forms-OR ', wherein R' is aryl as defined herein. For example, the group-O (C) 6 H 6 ) May be referred to herein as "phenoxy".
As used herein, the term "hydrogen" includes two stable isotopes of hydrogen, namely 1H (also referred to as protium) and 2 h (also known as deuterium).
As used herein, the term "carboxy" refers to a group that forms a-C (O) OH.
In a preferred embodiment, R 1 、R 2 And R 3 Each independently selected from hydrogen and C 1 -C 6 Alkyl groups. For example, R 1 、R 2 And R 3 May each be independently selected from the group consisting of hydrogen and methyl. In a preferred embodiment, R 1 And R 2 Each independently selected from the group consisting of C 1 -C 6 In the group of alkyl radicals and R 3 Is hydrogen.
In some embodiments, each Ar is 2 Are the same. For example, each Ar 2 Can be part of structure (4) wherein each X is the same. In other embodiments, each Ar 2 Is part of the structure (5).
In a preferred embodiment, X is selected from the group consisting of-CH 2 -and-C (CH) 3 ) 2 -in the group consisting of. For example, X may be-C (CH) 3 ) 2 -。
In a preferred embodiment, n is an integer from 1 to 10. For example, n may be 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. In one exemplary embodiment, n is 1.
For example, provided herein are compounds of formula I,
Figure BDA0003966987840000091
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which is optionally independently selected from the group consisting of methylEthyl, methoxy;
each Ar 2 Independently selected from the group consisting of structure (4), structure (5), structure (6), structure (7), structure (8), and structure (9);
each X is independently selected from the group consisting of-CH 2 -、-C(CH 3 ) 2 -、-S-、-SO 2 -, -O-and-CO-;
R 6 and R 7 Each independently selected from the group consisting of hydrogen and alkyl, aryl, alkoxy, and aryloxy groups, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
and n is an integer greater than or equal to 1.
In general, each R 1 、R 2 、R 3 、Ar 2 X and n may be selected as described above with respect to formula a.
In a preferred embodiment of the compounds of formula I, R 1 、R 2 And R 3 Each independently selected from hydrogen and C 1 -C 6 Alkyl groups. For example, R 1 、R 2 And R 3 May be each independently selected from the group consisting of hydrogen and methyl. In a preferred embodiment, R 1 And R 2 Each independently selected from the group consisting of C 1 -C 6 In the group consisting of alkyl radicals and R 3 Is hydrogen.
In a preferred embodiment of the compounds of formula I, ar 2 Selected from the group consisting of Structure (4) and Structure (5), and each Ar 2 Are the same.
In exemplary embodiments of the compounds of formula I, ar 2 Is a moiety of structure (4), and X is selected from the group consisting of-CH 2 -and-C (CH) 3 ) 2 -in the group of compositions. For example, X may be-C (CH) 3 ) 2 -。
In a preferred embodiment of the compounds of formula I, n is 1.
For example, when Ar 2 Is part of structure (4), the compound has formula Ia,
Figure BDA0003966987840000101
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
each X is independently selected from the group consisting of-CH 2 -、-C(CH 3 ) 2 -、-S-、-SO 2 -, -O-and-CO-;
and n is an integer greater than or equal to 1.
In general, R 1 、R 2 、R 3 X and n are each as described above with respect to formula a and/or formula I.
In a preferred embodiment of the compound of formula Ia, R 1 、R 2 And R 3 Each independently selected from hydrogen and C 1 -C 6 Alkyl groups. For example, R 1 、R 2 And R 3 May each be independently selected from the group consisting of hydrogen and methyl. In a preferred embodiment, R 1 And R 2 Each independently selected from C 1 -C 6 In the group of alkyl radicals and R 3 Is hydrogen.
In a preferred embodiment of the compound of formula Ia, X is selected from the group consisting of-CH 2 -and-C (CH) 3 ) 2 -in the group consisting of. For example, X may be-C (CH) 3 ) 2 -。
In a preferred embodiment of the compound of formula Ia, n is 1.
In an exemplary embodiment, R 1 And R 2 Is methyl, R 3 Is hydrogen, X is-C (CH) 3 ) 2 N is 1 and the compound is of formula Ia-i.
Figure BDA0003966987840000111
Further provided herein are compounds of formula II,
Figure BDA0003966987840000112
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
each Ar 2 Independently selected from the group consisting of structure (4), structure (5), structure (6), structure (7), structure (8), and structure (9);
each X is independently selected from the group consisting of-CH 2 -、-C(CH 3 ) 2 -、-S-、-SO 2 -, -O-and-CO-;
R 6 and R 7 Each independently selected from the group consisting of hydrogen and alkyl, aryl, alkoxy, and aryloxy groups, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
and n is an integer greater than or equal to 1.
In general, R 1 、R 2 、R 3 、Ar 2 X and n may each be selected as described above with respect to formula a.
In a preferred embodiment of the compounds of formula II, R 1 、R 2 And R 3 Each independently selected from hydrogen and C 1 -C 6 Alkyl groups. For example, R 1 、R 2 And R 3 May be each independently selected from the group consisting of hydrogen and methyl. In a preferred embodiment, R 1 And R 2 Each independently selected from the group consisting of C 1 -C 6 In the group consisting of alkyl radicals and R 3 Is hydrogen.
In a preferred embodiment of the compound of formula II, ar 2 Selected from the group consisting of structure (4) and structure (5), and each Ar 2 Are the same。
In exemplary embodiments of the compounds of formula II, ar 2 Is a moiety of structure (4), and X is selected from the group consisting of-CH 2 -and-C (CH) 3 ) 2 -in the group of compositions. For example, X may be-C (CH) 3 ) 2 -。
In a preferred embodiment of the compound of formula II, n is 1.
For example, when Ar 2 When part of structure (4), the compound has formula IIa,
Figure BDA0003966987840000121
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
x is selected from the group consisting of-CH 2 -、-C(CH 3 ) 2 -、-S-、-SO 2 -, -O-and-CO-;
and n is an integer greater than or equal to 1.
In general, R 1 、R 2 、R 3 X and n can each be selected as described above with respect to formula a and/or formula II.
In a preferred embodiment of the compounds of formula IIa, R 1 、R 2 And R 3 Each independently selected from hydrogen and C 1 -C 6 Alkyl groups. For example, R 1 、R 2 And R 3 May each be independently selected from the group consisting of hydrogen and methyl. In a preferred embodiment, R 1 And R 2 Each independently selected from the group consisting of C 1 -C 6 In the group of alkyl radicals and R 3 Is hydrogen.
In a preferred embodiment of the compound of formula IIa, X is selected from the group consisting of-CH 2 -and-C (CH) 3 ) 2 -in the group of compositions. For example, X may be-C (CH) 3 ) 2 -。
In a preferred embodiment of the compound of formula IIa, n is 1.
In an exemplary embodiment, R 1 And R 2 Is methyl, R 3 Is hydrogen, X is-C (CH) 3 ) 2 -, n is 1, and the compound is of formula IIa-i.
Figure BDA0003966987840000131
Also provided herein are compounds of formula IIb,
Figure BDA0003966987840000132
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
and n is an integer greater than or equal to 1.
In general, R 1 、R 2 、R 3 And n can each be selected as described above with respect to formula a and/or formula II.
In a preferred embodiment of the compounds of formula IIb, R 1 、R 2 And R 3 Each independently selected from hydrogen and C 1 -C 6 Alkyl groups. For example, R 1 、R 2 And R 3 May each be independently selected from the group consisting of hydrogen and methyl. In a preferred embodiment, R 1 And R 2 Each independently selected from C 1 -C 6 In the group of alkyl radicals and R 3 Is hydrogen.
In a preferred embodiment of the compounds of formula IIb, n is 1.
In exemplary embodiments, R 1 And R 2 Is methyl, R 3 Is hydrogen, n is 1, and the compound is of formula IIb-i.
Figure BDA0003966987840000141
Also provided herein are compounds of formula IIc,
Figure BDA0003966987840000142
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
and n is an integer greater than or equal to 1.
In general, R 1 、R 2 、R 3 And n can each be selected as described above with respect to formula a and/or formula II.
In a preferred embodiment of compounds of formula IIc, R 1 、R 2 And R 3 Each independently selected from hydrogen and C 1 -C 6 Alkyl groups. For example, R 1 、R 2 And R 3 May each be independently selected from the group consisting of hydrogen and methyl. In a preferred embodiment, R 1 And R 2 Each independently selected from C 1 -C 6 In the group consisting of alkyl radicals and R 3 Is hydrogen.
In a preferred embodiment of the compounds of formula IIc, n is 1.
In exemplary embodiments, R 1 And R 2 Is methyl, R 3 Is hydrogen, n is 1, and the compound is of formula IIc-i.
Figure BDA0003966987840000151
Also provided herein are compounds of formula IId,
Figure BDA0003966987840000152
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
and n is an integer greater than or equal to 1.
In general, R 1 、R 2 、R 3 And n can each be selected as described above for formula a and/or formula II.
In a preferred embodiment of the compounds of formula IId, R 1 、R 2 And R 3 Each independently selected from hydrogen and C 1 -C 6 Alkyl groups. For example, R 1 、R 2 And R 3 May each be independently selected from the group consisting of hydrogen and methyl. In a preferred embodiment, R 1 And R 2 Each independently selected from C 1 -C 6 In the group consisting of alkyl radicals and R 3 Is hydrogen.
In a preferred embodiment of the compounds of formula IId, n is 1.
In exemplary embodiments, R 1 And R 2 Is methyl, R 3 Is hydrogen, n is 1, and the compound is of formula IId-i.
Figure BDA0003966987840000161
Also provided herein are compounds of formula IIe,
Figure BDA0003966987840000171
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more selected from the group consisting of methyl, ethyl, methoxy, and carboxylSubstituted by radicals;
and n is an integer greater than or equal to 1.
In general, R 1 、R 2 、R 3 And n can each be selected as described above with respect to formula a and/or formula II.
In preferred embodiments of compounds of formula IIe, R 1 、R 2 And R 3 Each independently selected from hydrogen and C 1 -C 6 Alkyl groups. For example, R 1 、R 2 And R 3 May each be independently selected from the group consisting of hydrogen and methyl. In a preferred embodiment, R 1 And R 2 Each independently selected from C 1 -C 6 In the group consisting of alkyl radicals and R 3 Is hydrogen.
In a preferred embodiment of the compounds of formula IIe, n is 1.
In exemplary embodiments, R 1 And R 2 Is methyl, R 3 Is hydrogen, n is 1, and the compound is of formula IIe-i.
Figure BDA0003966987840000181
Also provided herein are compounds of formula IIf,
Figure BDA0003966987840000182
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
each X is independently selected from the group consisting of-CH 2 -、-C(CH 3 ) 2 -、-S-、-SO 2 -, -O-and-CO-;
R 6 and R 7 Each independently selected from the group consisting of hydrogen and alkyl, aryl, alkoxy and aryloxy groups, each of which may beOptionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy and carboxyl;
and n is an integer greater than or equal to 1.
In general, R 1 、R 2 、R 3 、R 6 、R 7 X and n can each be selected as described above with respect to formula a and/or formula II.
In a preferred embodiment of the compounds of formula IIf, R 1 、R 2 And R 3 Each independently selected from hydrogen and C 1 -C 6 Alkyl groups. For example, R 1 、R 2 And R 3 May be each independently selected from the group consisting of hydrogen and methyl. In a preferred embodiment, R 1 And R 2 Each independently selected from C 1 -C 6 In the group of alkyl radicals and R 3 Is hydrogen.
In preferred embodiments of compounds of formula IIf, X is selected from the group consisting of-CH 2 -and-C (CH) 3 ) 2 -in the group of compositions. For example, X may be-C (CH) 3 ) 2 -。
In a preferred embodiment of the compounds of formula IIf, n is 1.
In exemplary embodiments, R 1 And R 2 Is methyl, R 3 、R 6 And R 7 Each is hydrogen, X is-C (CH) 3 ) 2 N is 1 and the compound is of formula IIf-i,
Figure BDA0003966987840000191
further provided herein are compounds of formula III,
Figure BDA0003966987840000192
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may optionally beIndependently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
each Ar 2 Independently selected from the group consisting of structure (4), structure (5), structure (6), structure (7), structure (8), and structure (9);
each X is independently selected from the group consisting of-CH 2 -、-C(CH 3 ) 2 -、-S-、-SO 2 -, -O-and-CO-;
R 6 and R 7 Each independently selected from the group consisting of hydrogen and alkyl, aryl, alkoxy, and aryloxy groups, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
and n is an integer greater than or equal to 1.
In general, R 1 、R 2 、R 3 、Ar 2 X and n can each be selected as described above with respect to formula a.
In a preferred embodiment of the compound of formula III, R 1 、R 2 And R 3 Each independently selected from hydrogen and C 1 -C 6 Alkyl groups. For example, R 1 、R 2 And R 3 May each be independently selected from the group consisting of hydrogen and methyl. In a preferred embodiment, R 1 And R 2 Each independently selected from C 1 -C 6 In the group consisting of alkyl radicals and R 3 Is hydrogen.
In a preferred embodiment of the compound of formula III, ar 2 Selected from the group consisting of structure (4) and structure (5), and each Ar 2 Are the same.
In exemplary embodiments of the compounds of formula III, ar 2 Is a moiety of structure (4), and X is selected from the group consisting of-CH 2 -and-C (CH) 3 ) 2 -in the group consisting of. For example, X may be-C (CH) 3 ) 2 -。
In a preferred embodiment of the compound of formula III, n is 1.
For example, when Ar 2 Is part of structure (4)The compounds have the formula IIIa,
Figure BDA0003966987840000201
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
x is selected from the group consisting of-CH 2 -、-C(CH 3 ) 2 -、-S-、-SO 2 -, -O-and-CO-;
and n is an integer greater than or equal to 1.
In general, R 1 、R 2 、R 3 X and n may each be selected as described above with respect to formula a and/or formula III.
In a preferred embodiment of compounds of formula IIIa, R 1 、R 2 And R 3 Each independently selected from hydrogen and C 1 -C 6 Alkyl groups. For example, R 1 、R 2 And R 3 May be each independently selected from the group consisting of hydrogen and methyl. In a preferred embodiment, R 1 And R 2 Each independently selected from the group consisting of C 1 -C 6 In the group of alkyl radicals and R 3 Is hydrogen.
In a preferred embodiment of the compound of formula IIIa, X is selected from the group consisting of-CH 2 -and-C (CH) 3 ) 2 -in the group consisting of. For example, X may be-C (CH) 3 ) 2 -。
In a preferred embodiment of the compound of formula IIIa, n is 1.
In exemplary embodiments, R 1 And R 2 Is methyl, R 3 Is hydrogen, X is-C (CH) 3 ) 2 N is 1 and the compound is of formula IIIa-i.
Figure BDA0003966987840000211
Also provided herein are compounds of formula IIIb,
Figure BDA0003966987840000212
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
and n is an integer greater than or equal to 1.
In general, R 1 、R 2 、R 3 And n can each be selected as described above with respect to formula a and/or formula III.
In a preferred embodiment of compounds of formula IIIb, R 1 、R 2 And R 3 Each independently selected from hydrogen and C 1 -C 6 Alkyl groups. For example, R 1 、R 2 And R 3 May be each independently selected from the group consisting of hydrogen and methyl. In a preferred embodiment, R 1 And R 2 Each independently selected from the group consisting of C 1 -C 6 In the group consisting of alkyl radicals and R 3 Is hydrogen.
In a preferred embodiment of the compound of formula IIIb, n is 1.
In exemplary embodiments, R 1 And R 2 Is methyl, R 3 Is hydrogen, n is 1, and the compound is of formula IIIb-i.
Figure BDA0003966987840000221
Also provided herein are compounds of formula IIIc,
Figure BDA0003966987840000222
Figure BDA0003966987840000231
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
and n is an integer greater than or equal to 1.
In general, R 1 、R 2 、R 3 And n can each be selected as described above with respect to formula a and/or formula III.
In a preferred embodiment of compounds of formula IIIc, R 1 、R 2 And R 3 Each independently selected from hydrogen and C 1 -C 6 Alkyl groups. For example, R 1 、R 2 And R 3 May be each independently selected from the group consisting of hydrogen and methyl. In a preferred embodiment, R 1 And R 2 Each independently selected from the group consisting of C 1 -C 6 In the group consisting of alkyl radicals and R 3 Is hydrogen.
In a preferred embodiment of the compound of formula IIIc, n is 1.
In an exemplary embodiment, R 1 And R 2 Is methyl, R 3 Is hydrogen, n is 1, and the compound is of formula IIIc-i.
Figure BDA0003966987840000232
Also provided herein are compounds of formula IIId,
Figure BDA0003966987840000241
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may optionally beIndependently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy and carboxyl;
and n is an integer greater than or equal to 1.
In general, R 1 、R 2 、R 3 And n can each be selected as described above with respect to formula a and/or formula III.
In a preferred embodiment of the compound of formula Id, R 1 、R 2 And R 3 Each independently selected from hydrogen and C 1 -C 6 Alkyl groups. For example, R 1 、R 2 And R 3 May each be independently selected from the group consisting of hydrogen and methyl. In a preferred embodiment, R 1 And R 2 Each independently selected from C 1 -C 6 In the group consisting of alkyl radicals and R 3 Is hydrogen.
In a preferred embodiment of the compound of formula IIId, n is 1.
In exemplary embodiments, R 1 And R 2 Is methyl, R 3 Is hydrogen, n is 1, and the compound is of formula IIId-i.
Figure BDA0003966987840000251
Also provided herein are compounds of formula IIIe,
Figure BDA0003966987840000252
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
and n is an integer greater than or equal to 1.
In general, R 1 、R 2 、R 3 And n can each be selected as described above with respect to formula a and/or formula III.
In a preferred embodiment of compounds of formula IIIe, R 1 、R 2 And R 3 Each independently selected from hydrogen and C 1 -C 6 Alkyl groups. For example, R 1 、R 2 And R 3 May each be independently selected from the group consisting of hydrogen and methyl. In a preferred embodiment, R 1 And R 2 Each independently selected from C 1 -C 6 In the group consisting of alkyl radicals and R 3 Is hydrogen.
In a preferred embodiment of the compound of formula IIIe, n is 1.
In exemplary embodiments, R 1 And R 2 Is methyl, R 3 Is hydrogen, n is 1, and the compound is of formula IIIe-i.
Figure BDA0003966987840000261
Also provided herein are compounds of formula IIIf,
Figure BDA0003966987840000262
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
each X is independently selected from the group consisting of-CH 2 -、-C(CH 3 ) 2 -、-S-、-SO 2 -, -O-and-CO-;
R 6 and R 7 Each independently selected from the group consisting of hydrogen and alkyl, aryl, alkoxy, and aryloxy groups, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
and n is an integer greater than or equal to 1.
In general terms, the term "water-soluble" is used to describe a mixture of water-soluble polymers and water-soluble polymers,R 1 、R 2 、R 3 、R 6 、R 7 X and n can each be selected as described above with respect to formula a and/or formula III.
In a preferred embodiment of the compounds of formula IIIf, R 1 、R 2 And R 3 Each independently selected from hydrogen and C 1 -C 6 Alkyl groups. For example, R 1 、R 2 And R 3 May each be independently selected from the group consisting of hydrogen and methyl. In a preferred embodiment, R 1 And R 2 Each independently selected from C 1 -C 6 In the group consisting of alkyl radicals and R 3 Is hydrogen.
In a preferred embodiment of the compound of formula IIIf, X is selected from the group consisting of-CH 2 -and-C (CH) 3 ) 2 -in the group consisting of. For example, X may be-C (CH) 3 ) 2 -。
In a preferred embodiment of the compound of formula IIIf, n is 1.
In exemplary embodiments, R 1 And R 2 Is methyl, R 3 、R 6 And R 7 Each is hydrogen, X is-C (CH) 3 ) 2 N is 1 and the compound is of formula IIIf-i.
Figure BDA0003966987840000271
Composition and printed circuit board
Also provided herein are curable unsaturated resin compositions, wherein the composition comprises at least one unsaturated resin and a flame retardant compound selected from the group consisting of formula a, formula I, formula Ia, formula Ib, formula Ic, formula Id, formula Ie, formula If, formula II, formula IIa, formula IIb, formula IIc, formula IId, formula IIe, formula IIf, formula III, formula IIIa, formula IIIb, formula IIIc, formula IIId, formula IIIe, and formula IIIf.
Also provided herein are cured unsaturated resin compositions, wherein the unsaturated resin composition comprises a flame retardant compound selected from the group consisting of formula a, formula I, formula Ia, formula Ib, formula Ic, formula Id, formula Ie, formula If, formula II, formula IIa, formula IIb, formula IIc, formula IId, formula IIe, formula IIf, formula III, formula IIIa, formula IIIb, formula IIIc, formula IIId, formula IIIe, and formula IIIf.
Also provided herein are printed circuit boards comprising a cured unsaturated resin composition, wherein the unsaturated resin composition comprises a flame retardant compound selected from the group consisting of formula a, formula I, formula Ia, formula Ib, formula Ic, formula Id, formula Ie, formula If, formula II, formula IIa, formula IIb, formula IIc, formula IId, formula IIe, formula IIf, formula III, formula IIIa, formula IIIb, formula IIIc, formula IIId, formula IIIe, and formula IIIf.
Other objects and features will be in part apparent and in part pointed out hereinafter.
Examples
The following non-limiting examples are provided to further illustrate the present disclosure.
Example 1: experimental Material
The compounds provided herein can be synthesized using typical techniques known to those skilled in the art. Representative examples of methods that may be used to synthesize particular compounds within the scope of the disclosure are set forth below.
Unless otherwise indicated, the materials described below are used in each of the following examples.
SA9000 (obtained from SABIC) is an acrylate-capped polyphenylene ether.
TAIC (obtained from Tokyo Chemical Industry Co.) is triallyl isocyanurate.
SPB100 (obtained from Otsuka Chemical Co.) is hexaphenoxycyclotriphosphazene.
PX200 (available from Daihachi Chemical Industry Co.) is resorcinol bis [ bis (2, 6-dimethylphenyl) phosphate ].
DCP (obtained from Sinopharm Chemical Reagent Co.) is dicumyl peroxide.
Abbreviations (tBuO) as used herein 2 Refers to di-tert-butyl peroxide (obtained from Sinopharm Chemical Reagent Co.).
Example 2: synthesis of Compounds of formula Ia
The compounds provided herein can be synthesized using typical techniques known to those skilled in the art. An exemplary synthesis of the compound of formula Ia is provided below.
In the first step of the synthesis (step a), 244 grams of 2, 6-dimethylphenol (starting material), 50 grams of xylene (solvent), and 2 grams of anhydrous magnesium chloride (catalyst) were combined in a reactor. The temperature of the reactor was increased to 100 ℃. The reactor was slowly charged with 153 g of phosphorus oxychloride and maintained at 100 ℃ for 4 hours. The temperature was then increased to 160 ℃ for 4 hours, which yielded the phase of step a.
Figure BDA0003966987840000291
In the second step of the synthesis (step B), 154.5 grams of diallyl bisphenol a was combined with the crude product of step a and held at a temperature of 160 ℃ for 4 hours to produce the final product of formula Ia.
Figure BDA0003966987840000292
Example 3: evaluation of Compounds of formula Ia
Two comparative formulations and two inventive formulations were prepared as described in table 1 below.
TABLE 1
Figure BDA0003966987840000293
Figure BDA0003966987840000301
Example 3a: clear casting application
Inventive examples prepared as described in example 3 were tested for use in transparent casting applications.
A mixed resin composition was prepared by combining the formulation prepared as described in example 3 with a methyl ethyl ketone solvent (50% by weight of the mixed resin composition). 2-3 g of the mixed resin was poured onto an aluminum plate. The aluminum plate was then placed on a 100 ℃ hot plate to slowly remove the solvent. After removal of the solvent, the hot plate was heated to 200 ℃ for 1 hour of post-curing. After post-curing, the cured resin was carefully peeled from the aluminum plate and tested for the properties shown in table 2 below.
Table 2 shows that compositions containing the novel compounds of formula Ia exhibit ultra-low loss properties when used in clear casting applications.
TABLE 2
Figure BDA0003966987840000302
Figure BDA0003966987840000311
Example 3b: laminate applications
Comparative and inventive examples prepared as described in example 3 were tested for use in laminates.
A varnish was prepared by combining the prepared formulation described in example 3 with methyl ethyl ketone solvent (50% by weight of the varnish composition). About 200 grams of varnish was poured into the tray. A piece 7628 of glass cloth (about 30 cm. Times.30 cm) was dipped into the varnish and then pulled by hand through a pair of gapped rollers to control thickness. One edge of the prepared glass cloth was held with a clip and then hung in a fume hood to allow the varnish to spread evenly and promote solvent evaporation. The glass cloth is then baked in a small processor (with good ventilation) at elevated temperature for a period of time sufficient to remove the solvent and produce a reasonable prepreg gel time, so the temperature and time can be adjusted as appropriate. After baking, the desired prepreg was obtained.
Two of the resulting prepregs were stacked together with half of the top and bottom surfaces covered with 35um standard copper foil. The stack was then laminated in a press at 200 ℃ for 1.0 hour. The resulting laminate composition was then tested for the characteristics shown in table 3 below.
Table 3 shows that compositions comprising compounds of formula Ia provide a desirable balance between Tg, td and Df when used in laminates.
: TABLE 3
Figure BDA0003966987840000312
Figure BDA0003966987840000321
Example 4: synthesis of Compounds of formula IIb
An exemplary synthesis of the compound of formula IIb is provided below.
Figure BDA0003966987840000322
At N 2 122g of 2, 6-dimethylphenol, 111.1g of Et were reacted at 0 ℃ over 2 hours in a 2L flask with mechanical stirring under protection 3 A solution of N and 122g EtOAc was slowly added 153.5g POCl 3 And 307g EtOAc. After that, the reaction mixture was stirred at room temperature for 1h. 77g of resorcinol and 155.54g of Et were slowly added at 0 ℃ over 1 hour 3 N and 77g EtOAc. After that, the reaction mixture was stirred at room temperature for 1h. 61.1g of diallylamine and 66.8g of Et are added 3 A mixture of N. The reaction mixture was stirred at room temperature overnight. The reaction was quenched with 400mL of water. The organic phase was washed once with 150mL of diluted HCl, and 3 times with 100mL of water and over Na 2 SO 4 And drying. After removal of the solvent, 300g of the final product are obtained.
Example 5: evaluation of Compounds of formula IIb
Inventive formulations including compounds of formula IIb were prepared as described in table 4 below.
TABLE 4
Figure BDA0003966987840000323
Figure BDA0003966987840000331
Inventive example 3 shown in the table above was tested for use in laminate applications (with 2116 glass cloth).
A varnish was prepared by combining the formulation of invention example 3 with methyl ethyl ketone solvent (50% by weight of the varnish composition). About 200 grams of varnish was poured into the tray. A piece of 2116 glass cloth (about 30 cm. Times.30 cm) was dipped into the varnish and then pulled by hand through a pair of gapped rollers to control thickness. One edge of the prepared glass cloth was fixed with a clip and then hung in a fume hood to allow the varnish to spread uniformly and to promote solvent evaporation. The glass cloth is then baked in a small processor (with good ventilation) at elevated temperatures for a period of time sufficient to remove the solvent and produce a reasonable prepreg gel time, so the temperature and time can be adjusted as appropriate. After baking, the desired prepreg is obtained.
Six of the resulting prepregs were stacked together with half of the top and bottom surfaces covered with 35um standard copper foil. The stack was then laminated in a press at 200 ℃ for 1.0 hour. The resulting laminate composition was then tested for the properties shown in table 5 below.
Table 5 shows the results of the laminate performance evaluation (with 2116 glass cloth) for the formulation of inventive example 3. The formulation achieves a relatively high Tg of 178 ℃ and a relatively low Df of 0.0054 at 10 GHz.
TABLE 5
Figure BDA0003966987840000332
Figure BDA0003966987840000341
With 3.3% total phosphorus content in the formulation of invention example 3, the UL94 fire rating of the laminate is worse than V-1. It is believed that flame retardancy can be improved by increasing the filler loading in the formulation. As shown in inventive example 4, the laminate achieved a V-1 flame rating with the same 3.3% phosphorus content and increased filler loading. Specifically, with high filler loading and a total phosphorus content increased to 6.0%, the flame retardancy achieved a V-0 rating.
TABLE 6
Figure BDA0003966987840000342
Example 6: synthesis of Compounds of formula IIa
An exemplary synthesis of a compound of formula IIa is provided below.
Figure BDA0003966987840000343
In N 2 In a 2L flask with mechanical stirring, 122g of 2,6-dimethylphenol, 111.1g of Et were added over 2 hours at 0 ℃ under protection 3 A solution of N and 122g EtOAc was slowly added 153.5g POCl 3 And 307g EtOAc. After that, the reaction mixture was stirred at room temperature for 1h. 215.90g of diallyl bisphenol A and 155.54g of Et were slowly added at room temperature over 2h 3 N and 216g EtOAc. Thereafter, the reaction mixture was heated at 70 ℃ for 1h. 61.1g of diallylamine and 66.8g of Et are added 3 A mixture of N. The reaction mixture was stirred at room temperature overnight. The reaction was quenched with 400mL of water. The organic phase was washed once with 150mL of diluted HCl, and 100 m Washed 3 times with L water and over Na 2 SO 4 And drying. After removal of the solvent, 400g of the final product were obtained.
Example 7: evaluation of Compounds of formula IIa
An inventive formulation comprising a compound of formula IIa was prepared as described in table 7 below.
TABLE 7
Formulation of Inventive example 7 (3.3% P)
SA9000(PPO) 80.0
TAIC --
A compound of formula IIa 70.0
Dicumyl peroxide/di-tert-butyl peroxide 4.5
Filler material --
Inventive example 7 shown in the table above was tested for use in laminate applications (with 2116 glass cloth).
A varnish was prepared by combining the formulation of invention example 7 with methyl ethyl ketone solvent (50% by weight of the varnish composition). About 400 grams of varnish was poured into the tray. A piece of 2116 glass cloth (about 30 cm. Times.30 cm) was immersed in the varnish and then pulled by hand through a pair of gapped rollers to control the thickness. One edge of the prepared glass cloth was held with a clip and then hung in a fume hood to allow the varnish to spread evenly and to promote solvent evaporation. The glass cloth is then baked in a small processor (with good ventilation) at elevated temperature for a period of time sufficient to remove the solvent and produce a reasonable prepreg gel time, so the temperature and time can be adjusted as appropriate. After baking, the desired prepreg is obtained.
Six pieces of the resulting prepreg were stacked together and half of the top and bottom surfaces were covered with 35um standard copper foil. The stack was then laminated in a press at 200 ℃ for 1.0 hour. The resulting laminate composition was then tested for the properties shown in table 8 below.
The formulation achieves a high Tg of 182 ℃ and a low Df of 0.0054 at 10 GHz. However, the flame retardancy is worse than the V-1 rating.
TABLE 8
Laminate, 6 ply @2116 Inventive example 7 (3.3% P)
Tg(℃,DSC) 182
Td(℃,N 2 5 The wt loss) 380
UL94 rating Is worse than V-1
Dk(1GHz) 3.53
Df(1GHz) 0.0028
Dk(10GHz) 3.49
Df(10GHz) 0.0054
Example 8: synthesis of Compounds of formula II
An exemplary synthesis of the compound of formula II is provided below.
Figure BDA0003966987840000371
In N 2 24.43g of 2, 6-dimethylphenol, 22.24g of Et were added over 40min at 0 ℃ in a 2L flask with mechanical stirring 3 A solution of N and 100mL EtOAc was added slowly to 30.67g POCl 3 And 50mL EtOAc. After that, the reaction mixture was stirred at room temperature for another 40min. Slowly add 30.99g diallyl bisphenol A and 22.25g Et over 50min at room temperature 3 N and 50mL EtOAc. Thereafter, the reaction mixture was heated at 70 ℃ for 1h. Adding 19.45g DOPHQ and 13.33g Et within 30min 3 N and 100mL of NMP. Thereafter, the reaction mixture was heated at 70 ℃ for a further 1.5h. 8.02g of diallylamine and 9.03g of Et were added 3 A mixture of N. The reaction mixture was stirred at room temperature overnight. The reaction was quenched with 200mL water and extracted twice with 300mL EtOAc. The combined organic phases were washed once with 150mL of diluted HCl, and 3 times with 150mL of water and over Na 2 SO 4 And drying. After removal of the solvent, 83.74g of the final product are obtained.
Example 9: evaluation of Compounds of formula II
Inventive formulations including the compound of formula II were prepared as described in table 9 below.
TABLE 9
Figure BDA0003966987840000372
Figure BDA0003966987840000381
Inventive example 8 shown in the table above was tested for use in laminate applications (with 2116 glass cloth).
A varnish was prepared by combining the formulation of invention example 8 with methyl ethyl ketone solvent (50% by weight of the varnish composition). About 200 grams of varnish was poured into the tray. A piece of 2116 glass cloth (about 30 cm. Times.30 cm) was immersed in the varnish and then pulled by hand through a pair of gapped rollers to control the thickness. One edge of the prepared glass cloth was held by a clip and then hung in a fume hood to allow the varnish to spread evenly and to promote solvent evaporation. The glass cloth is then baked in a small processor (with good ventilation) at elevated temperature for a period of time sufficient to remove the solvent and produce a reasonable prepreg gel time, so the temperature and time can be adjusted as appropriate. After baking, the desired prepreg is obtained.
Six pieces of the resulting prepreg were stacked together and half of the top and bottom surfaces were covered with 35um standard copper foil. The stack was then laminated in a press at 200 ℃ for 1.0 hour. The resulting laminate composition was then tested for the properties shown in table 5 below.
Compared to inventive example 7, this formulation achieved better flame retardancy, almost approaching V-0 (50 s). The laminate also had a relatively high Tg of 169 deg.C, while the Df of 0.0068 at 10GHz was worse than that of inventive example 7.
Watch 10
Figure BDA0003966987840000382
Figure BDA0003966987840000391
When introducing elements of the present disclosure or the preferred embodiments thereof, the articles "a," "an," "the," and "said" are intended to mean that there are one or more of the elements. The terms "comprising," "including," and "having" are intended to be inclusive and mean that there may be additional elements other than the listed elements.
In view of the above, it will be seen that the several objects of the disclosure are achieved and other advantageous results attained.
As various changes could be made in the above products and methods without departing from the scope of the disclosure, it is intended that all matter contained in the above description shall be interpreted as illustrative and not in a limiting sense.

Claims (32)

1. A compound of the formula A, wherein,
Figure FDA0003966987830000011
wherein each Ar is 1 Independently is part of structure (1);
Figure FDA0003966987830000012
R 1 、R 2 and R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
R 4 and R 5 Each independently is a moiety comprising at least one C = C double bond;
each Ar 2 Independently selected from the group consisting of structure (4), structure (5), structure (6), structure (7), structure (8), and structure (9);
Figure FDA0003966987830000013
Figure FDA0003966987830000021
each X is independently selected from the group consisting of-CH 2 -、-C(CH 3 ) 2- 、-S-、-SO 2 -, -O-and-CO-;
R 6 and R 7 Each independently selected from the group consisting of hydrogen and alkyl, aryl, alkoxy, and aryloxy groups, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
and n is an integer greater than or equal to 1.
2. The compound of claim 1, wherein R 4 And R 5 Each independently selected from the group consisting of structure (1), structure (2), and structure (3):
Figure FDA0003966987830000022
3. a compound of the formula I, wherein,
Figure FDA0003966987830000031
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
each Ar 2 Independently selected from the group consisting of structure (4), structure (5), structure (6), and a junctionStructure (7), structure (8) and structure (9);
Figure FDA0003966987830000032
Figure FDA0003966987830000041
each X is independently selected from the group consisting of-CH 2 -、-C(CH 3 ) 2 -、-S-、-SO 2 -, -O-and-CO-;
R 6 and R 7 Each independently selected from the group consisting of hydrogen and alkyl, aryl, alkoxy, and aryloxy groups, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
and n is an integer greater than or equal to 1.
4. The compound of claim 3, wherein the compound has formula Ia,
Figure FDA0003966987830000042
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
x is selected from the group consisting of-CH 2 -、-C(CH 3 ) 2 -、-S-、-SO 2 -, -O-and-CO-;
and n is an integer greater than or equal to 1.
5. The compound of claim 4, wherein X is selected from the group consisting of-CH 2 -and-C (CH) 3 ) 2 -in the group of compositions.
6. A compound of the formula (II) wherein,
Figure FDA0003966987830000051
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
each Ar 2 Independently selected from the group consisting of structure (4), structure (5), structure (6), structure (7), structure (8), and structure (9);
Figure FDA0003966987830000052
Figure FDA0003966987830000061
each X is independently selected from the group consisting of-CH 2 -、-C(CH 3 ) 2- 、-S-、-SO 2 -, -O-and-CO-;
R 6 and R 7 Each independently selected from the group consisting of hydrogen and alkyl, aryl, alkoxy, and aryloxy groups, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
and n is an integer greater than or equal to 1.
7. The compound of claim 6, wherein the compound is of formula IIa,
Figure FDA0003966987830000062
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
x is selected from the group consisting of-CH 2 -、-C(CH 3 ) 2 -、-S-、-SO 2 -, -O-and-CO-;
and n is an integer greater than or equal to 1.
8. The compound of claim 7, wherein X is selected from the group consisting of-CH 2 -and-C (CH) 3 ) 2 -in the group of compositions.
9. The compound of claim 6, wherein the compound is of formula IIb,
Figure FDA0003966987830000071
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
and n is an integer greater than or equal to 1.
10. The compound of claim 6, wherein the compound is of formula IIc,
Figure FDA0003966987830000072
wherein R is 1 、R 2 And R 3 Each independently selected from hydrogen, alkyl, arylA group consisting of aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
and n is an integer greater than or equal to 1.
11. The compound of claim 6, wherein the compound is of formula IId,
Figure FDA0003966987830000081
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
and n is an integer greater than or equal to 1.
12. The compound of claim 6, wherein the compound is of formula IIe,
Figure FDA0003966987830000082
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
and n is an integer greater than or equal to 1.
13. The compound of claim 6, wherein the compound is of formula IIf,
Figure FDA0003966987830000091
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
each X is independently selected from the group consisting of-CH 2 -、-C(CH 3 ) 2 -、-S-、-SO 2 -, -O-and-CO-;
R 6 and R 7 Each independently selected from the group consisting of hydrogen and alkyl, aryl, alkoxy, and aryloxy groups, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
and n is an integer greater than or equal to 1.
14. The compound of claim 13, wherein X is selected from the group consisting of-CH 2 -and-C (CH) 3 ) 2 -in the group of compositions.
15. A compound of the formula (III),
Figure FDA0003966987830000101
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
each Ar 2 Independently selected from the group consisting of structure (4), structure (5), structure (6), structure (7), structure (8), and structure (9);
Figure FDA0003966987830000102
Figure FDA0003966987830000111
each X is independently selected from the group consisting of-CH 2 -、-C(CH 3 ) 2 -、-S-、-SO 2 -, -O-and-CO-;
R 6 and R 7 Each independently selected from the group consisting of hydrogen and alkyl, aryl, alkoxy, and aryloxy groups, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
and n is an integer greater than or equal to 1.
16. The compound of claim 15, wherein the compound has formula IIIa,
Figure FDA0003966987830000112
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
x is selected from the group consisting of-CH 2 -、-C(CH 3 ) 2 -、-S-、-SO 2 -, -O-and-CO-;
and n is an integer greater than or equal to 1.
17. The compound of claim 16, wherein X is selected from the group consisting of-CH 2 -and-C (CH) 3 ) 2 -in the group consisting of.
18. The compound of claim 15, wherein the compound has formula IIIb,
Figure FDA0003966987830000121
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
and n is an integer greater than or equal to 1.
19. The compound of claim 15, wherein the compound has formula IIIc,
Figure FDA0003966987830000122
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
and n is an integer greater than or equal to 1.
20. The compound of claim 15, wherein the compound has formula IIId,
Figure FDA0003966987830000131
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
and n is an integer greater than or equal to 1.
21. The compound of claim 15, wherein the compound has formula IIIe,
Figure FDA0003966987830000132
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
and n is an integer greater than or equal to 1.
22. The compound of claim 15, wherein the compound has formula IIIf,
Figure FDA0003966987830000141
wherein R is 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen, alkyl, aryl, alkoxy, and aryloxy, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, and carboxyl;
each X is independently selected from the group consisting of-CH 2 -、-C(CH 3 ) 2 -、-S-、-SO 2 -, -O-and-CO-;
R 6 and R 7 Each independently selected from the group consisting of hydrogen and alkyl, aryl, alkoxy, and aryloxy groups, each of which may be optionally independently substituted with one or more substituents selected from the group consisting of methyl, ethyl, methoxy, carboxyl;
and n is an integer greater than or equal to 1.
23. The combination of claim 22Wherein X is selected from the group consisting of-CH 2 -and-C (CH) 3 ) 2 -in the group of compositions.
24. The compound according to any one of claims 1 to 23, wherein R 1 、R 2 And R 3 Each independently selected from hydrogen and C 1 -C 6 Alkyl groups.
25. The compound according to any one of claims 1 to 23, wherein R 1 、R 2 And R 3 Each independently selected from the group consisting of hydrogen and methyl.
26. The compound according to any one of claims 1 to 25, wherein R 3 Is hydrogen.
27. The compound according to any one of claims 1 to 26, wherein n is an integer from 1 to 10.
28. The compound according to any one of claims 1 to 27, wherein n is 1.
29. A compound selected from the group consisting of:
formula Ia-i:
Figure FDA0003966987830000151
formula IIa-i:
Figure FDA0003966987830000152
formula IIb-i:
Figure FDA0003966987830000161
formula IIc-i:
Figure FDA0003966987830000162
formula IId-i:
Figure FDA0003966987830000163
Figure FDA0003966987830000171
formula IIe-i:
Figure FDA0003966987830000172
formula IIf-i:
Figure FDA0003966987830000173
formulae IIIa-i:
Figure FDA0003966987830000174
Figure FDA0003966987830000181
formula IIIb-i:
Figure FDA0003966987830000182
formula IIIc-i:
Figure FDA0003966987830000183
formula IIId-i:
Figure FDA0003966987830000191
formulas IIIe-I:
Figure FDA0003966987830000192
and formulae IIIf-I:
Figure FDA0003966987830000193
30. a curable unsaturated resin composition comprising the compound of any one of claims 1 to 29 and at least one unsaturated resin.
31. A cured unsaturated resin composition comprising a compound of any of claims 1 to 29 and at least one cured unsaturated resin.
32. A printed circuit board comprising the cured unsaturated resin composition of claim 31.
CN202080101474.9A 2020-05-29 2020-05-29 Reactive phosphate and preparation process thereof Pending CN115698157A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2020/093358 WO2021237695A1 (en) 2020-05-29 2020-05-29 Reactive type phosphate and preparation process

Publications (1)

Publication Number Publication Date
CN115698157A true CN115698157A (en) 2023-02-03

Family

ID=78745442

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080101474.9A Pending CN115698157A (en) 2020-05-29 2020-05-29 Reactive phosphate and preparation process thereof

Country Status (3)

Country Link
CN (1) CN115698157A (en)
TW (1) TW202144372A (en)
WO (1) WO2021237695A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062909A (en) * 1974-04-08 1977-12-13 Monsanto Company Phosphoroamidates
JPH07278318A (en) * 1994-04-08 1995-10-24 Asahi Chem Ind Co Ltd Flame-retardant part belonging to cd-rom
JP4318197B2 (en) * 1999-06-28 2009-08-19 大八化学工業株式会社 Method for producing condensed phosphate ester
JP2010077333A (en) * 2008-09-29 2010-04-08 Fuji Electric Fa Components & Systems Co Ltd Flame-retardant resin composition
KR102129650B1 (en) * 2013-04-01 2020-07-02 가부시키가이샤 아데카 Flame-retardant agent composition, flame-retardant fiber treated with flame-retardant agent composition, and method for increasing amount of flame-retardant component adhered onto fibers using said composition
WO2016029453A1 (en) * 2014-08-29 2016-03-03 Blue Cube Ip Llc Halogen-free and flame retardant compositions with low thermal expansion for high density printed wiring boards

Also Published As

Publication number Publication date
WO2021237695A1 (en) 2021-12-02
TW202144372A (en) 2021-12-01

Similar Documents

Publication Publication Date Title
US9399712B2 (en) Vinylbenzyl-etherified-DOPO compound resin composition and preparation and application thereof
JP5807186B2 (en) Polyphenylene ether resin composition, resin varnish, prepreg, metal-clad laminate, and printed wiring board
CN109762115B (en) Resin composition and application thereof
JP7269665B2 (en) Thermosetting resin composition containing flame retardant for thermosetting resin containing aromatic phosphate ester, cured product thereof, and use thereof
CN108148196B (en) Styryl siloxy polyphenylene oxide resin and preparation method and application thereof
TW201713674A (en) Phosphinated poly(2,6-dimethyl phenylene oxide) oligomers and thermosets thereof
CN110669328A (en) Resin composition containing phosphorus flame retardant BMI and application thereof
CN106946937A (en) A kind of phosphazene compound of cyano-containing, preparation method and purposes
TW201811809A (en) Phosphazene compound containing ester group, preparation method and use thereof
CN115698157A (en) Reactive phosphate and preparation process thereof
TW202206537A (en) Halogen free very low loss resin composition
CN108219434B (en) thermosetting resin composition, prepreg and laminated board
CN114230793B (en) Modified bismaleimide prepolymer and preparation method and application thereof
JP2661109B2 (en) Flame retardant phenolic resin composition
CN113121981B (en) Resin composition, prepreg and insulating plate using same
WO2022085221A1 (en) Unsaturated group-containing phosphoric acid ester, thermosetting resin composition containing same, and resin material
JP5812468B2 (en) Oligo (phenyleneoxy) group-containing cyclic phosphazene compound modified with cyanato group and production method thereof
JP2021113249A (en) Flame-retardant resin composition
TWI618713B (en) Phosphazene compound, prepreg and composite metal substrate
CN106565951B (en) Poly- (2,6 dimethyl phenylate) oligomer of phosphorus system and preparation method thereof and thermosetting compound
CN112480373A (en) Flame-retardant epoxy resin composition and preparation method and application thereof
TWI765504B (en) LOW EXPANSION COEFFICIENT, LOW Df, HIGH RIGIDITY, HALOGEN-FREE RESIN COMPOSITION, LAMINATES AND PRINTED CIRCUIT BOARDS
CN113563382B (en) Phosphorus-containing compound, epoxy resin containing same and composite laminated structure
TWI779446B (en) LOW EXPANSION COEFFICIENT, LOW Df, HIGH RIGIDITY, HALOGEN-FREE RESIN COMPOSITION, LAMINATES AND PRINTED CIRCUIT BOARDS
JPS6318968B2 (en)

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination